HR 4668 Introduction
- Rep. Paul Gosar (R-AZ) reintroduced HR 4668 to repeal protections for vaccine manufacturers from lawsuits.
- The goal is to allow individuals harmed by vaccines to sue in state or federal court.
## Background on Vaccine Liability
- Vaccine manufacturers have been largely immune from lawsuits since the National Childhood Vaccine Injury Act (NCVIA) in 1986.
- Individuals must seek compensation through the federal Vaccine Injury Compensation Program (VICP), which is criticized for being slow and inefficient.
## Context of the Bill
- The bill emerges amid growing concerns over vaccine safety, especially regarding COVID-19 vaccines.
- Aims to bypass the Countermeasures Injury Compensation Program (CICP), which approved only 39 of nearly 14,000 COVID-related claims.
## Arguments for and Against the Bill
- Proponents:
- Ending immunity would make manufacturers accountable.
- Could improve transparency regarding vaccines.
- Opponents:
- Warn that it might disrupt the vaccine supply.
- Citing past fears from the 1980s that litigation could drive companies out of production.
## Support and Current Status
- The bill has 28 cosponsors and bipartisan recognition of flaws in compensation systems.
- Its future remains uncertain.
## Additional Context
- Gosar, a former dentist, has previously introduced similar legislation, HR 9828, which also aimed to amend federal law to allow lawsuits against vaccine makers.
## Criticism of Current Systems
- VICP has paid about $5 billion across 25,000 claims, but critics argue the process is unfair and imposes high burdens on claimants.
## Potential Changes
- The bill could remove critical protections from NCVIA and the PREP Act of 2005.
- It would allow for retroactive claims dating back to the VICP's launch in 1988.
## Recent Discussions
- A Senate hearing highlighted the need for reform in vaccine liability, with some pro-vaccine lawmakers agreeing.
- Advocates describe NCVIA as a major error that eliminated accountability for manufacturers, while critics express concern over the stability of vaccine supply.
- Gosar and his supporters argue that litigation would encourage better transparency and safety among vaccine manufacturers.
https://www.naturalnews.com/2025-07-28-gosar-reintroduces-bill-ending-immunity-vaccine-makers.html
Comments
Post a Comment